Call for proposals for health data for biotech innovation leveraging the European Health Data Space
Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
The general objective of this action is to accelerate the development and deployment of AI and digital solutions in the biotech sector driven by health data, ensuring its secure and responsible use through the EHDS and leveraging AI Factories to augment these efforts.
Detailed Call Description
- Establish a multistakeholder platform/community of practice: create a platform that brings together biotech industry, research institutions, healthcare providers, patient organisations, and regulatory bodies and AI Factories to facilitate collaboration, knowledge-sharing among stakeholders, and the discussion of challenges in the use of AI in the biotechnology sector.
- Conduct a landscape analysis: map the current state of leveraging health data for AI in the biotech sector and identify the most relevant health datasets for the biotech sector, based on criteria such as potential impact on health outcomes, feasibility, and alignment with sectoral needs. Building on existing projects. Potentially incorporate also the AI Factories in this landscape analysis to also explore further application potential.
- Develop a strategic roadmap: create a roadmap for the development, deployment, and scale-up of effective AI solutions in the biotech sector, including recommendations for policy-makers, industry leaders, and researchers. Promote the adoption of standardized data formats and frameworks that facilitate the role data and research infrastructure relevant to the biotech sector, taking into account AI Factory capabilities and building on existing projects and activities in this area.
- Pilot the roles for health data infrastructures under the EHDS frameworks: This activity involves analysing and piloting the roles, and the potential federation of, specific health data infrastructures (genomic, cancer imaging, and brain) within the EHDS frameworks, as well as access to computing resources, and other related data and support services, to support AI-driven biotech innovations. The analysis shall examine the current state of these infrastructures, identify gaps and limitations, and pilot their integration with the EHDS frameworks to enable seamless data sharing and access. The goal is to demonstrate the value of these infrastructures in supporting AI applications in the biotech sector and provide recommendations for integration of such infrastructures into the EHDS frameworks.
- Develop case studies: create case studies of successful AI applications in the biotech sector, and share them with stakeholders to promote best practices, pathways and knowledge-sharing, these case studies should focus on explainable AI.
- Integrate AI Factory Expertise: Incorporate AI Factory technological advancements in collaboration with the use of the EHDS infrastructure, for simulations and analytics to refine and optimise biotech AI solutions, ensuring alignment with healthcare needs.
- Monitor and evaluate progress: pilot a methodology and tools to monitor and evaluate progress towards the strategic roadmap objectives, to provide insights and adjustments needed for continuous improvement.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
Indicative project budget: €14.386.810
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%).
You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’, i.e. concerns:
- actions where at least 30 % of the budget is allocated to Member States (or EU4H associated countries) whose GNI per inhabitant is less than 90% of the EU average or
- actions with bodies from at least 14 Member States (or EU4H associated countries) and where at least four are from Member States (or EU4H associated countries) whose GNI per inhabitant is less than 90% of the EU average.
Grants may NOT produce a profit (i.e. surplus of revenues + EU grant over costs).
For-profit organisations must declare their revenues and, if there is a profit, we will deduct it from the final grant amount.
Thematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Businesses
- Educational Institutions
- Large Enterprises
- Legal Entities
- NGOs
- Non Profit Organisations
- Other Beneficiaries
- Private Bodies
- Researchers/Research Centers/Institutions
- Semi-governmental organisations
- Small and Medium Enterprises (SMEs)
- State-owned Enterprises
Eligibility For Participation Notes
In order to be eligible, the applicants (beneficiaries and affiliated entities) must be legal entities (public or private bodies) established in EU Member States (including overseas countries and territories (OCTs)) or EEA countries and countries associated to the EU4Health Programme (list of participating countries).
For topic EU4H-2026-SANTE-PJ-08: Proposals must be submitted by a consortium of at least 5 beneficiaries from 5 different eligible countries.
Type of applicants targeted: biotech sector industry, developers of AI solutions, Member States’ authorities active in the area of secondary use of health data from at least 3 Member States, Research and health data infrastructures with experience in development and validation of AI solutions.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Telephone: 22605300/301, 22605617, 22605718
Address: Corner of Prodromou 1 & Chilonos 17 1448 Nicosia, Cyprus
Ms MAKRIGIORGI Elena
Email: emakrigiorgi@moh.gov.cy